ECAU
PTLA
Everett Capital Advisors (UK)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Hold |
0
| – | – | – | 34 |
|
|
2018
Q4 | – | Sell |
-855,476
| Closed | -$22.8M | – | 28 |
|
|
2018
Q3 | $22.8M | Buy |
855,476
+73,209
| +9% | +$1.95M | 3.32% | 10 |
|
|
2018
Q2 | $29.5M | Buy |
782,267
+231,094
| +42% | +$8.73M | 2.04% | 8 |
|
|
2018
Q1 | $18M | Buy |
551,173
+250,773
| +83% | +$8.19M | 1.52% | 20 |
|
|
2017
Q4 | $14.6M | Buy |
300,400
+96,400
| +47% | +$4.69M | 2.25% | 13 |
|
|
2017
Q3 | $11M | Buy |
+204,000
| New | +$11M | 1.63% | 14 |
|